Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

FORGOTTEN HISTORY: 4 - Caught on Camera

Too much vitamin B6 can be toxic. 3 symptoms to watch out for

Side effects from taking too much vitamin B6 – including nerve damage – may be more widespread than we think, Australia’s medicines regulator says.

The Conversation

Australians with ADHD could face drug shortages for rest of year, TGA says

People with neurodevelopmental disorder advised to contact their doctor while experts say alternative medications available

The Guardian - AU

Ban on gay and bisexual men donating blood and plasma in Australia to be scrapped

Lifeblood heralds ‘world-leading plasma pathway’ amid change to HIV-era restrictions

The Guardian - AU

From analysis to the latest developments in health,
read the most diverse news in one place.

Australia’s Sunscreen Saga Continues As CHOICE Doubles Down On Test Results

CHOICE has doubled down on its recent sunscreen testing, which found only four out of 20 popular sunscreens met their label claim of SPF50.

Pedestrian.tv

Low pharmacy vaping uptake fuels black market fears

Only about 40,000 vapes have been sold via the federal government's pharmacy model, which critics say shows black market sales are still thriving.

AAP

The weight loss drug Mounjaro has been approved to treat sleep apnoea. How does it work?

Last week, Australia’s Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, a condition in which breathing stops and starts repeatedly during sleep.

The Conversation

Australia's peak consumer advocacy group put 20 sunscreens to the test, finding most didn’t actually hit the SPF50 mark.

Pedestrian.tv

Read news from The Economist, FT, and more,
with one subscription

Four in five sunscreens fail SPF test: consumer group

The Cancer Council is disputing the findings of tests on popular sunscreens in Australia that show 16 out of 20 don't match the SPF 50+ ratings on their tubes.

AAP

Several leading Australian sunscreens don’t provide the protection they say, Choice finds

Consumer group tested 20 popular SPF 50 and 50+ brands and found 16 didn’t meet the claims on the bottles

The Guardian - AU

Tech giant sued over sleep aid foam inhalation 'risk'

Recalled Philips sleep apnoea devices posed dangers for users inhaling or ingesting small pieces of foam due to degradation, a government lawsuit claims.

AAP

The TGA has approved donanemab for Alzheimer’s disease. How does this drug work and who will be able to access it?

This week, Australia’s Therapeutic Goods Administration (TGA) approved a drug called donanemab for people in the early stages of Alzheimer’s disease.

The Conversation

'Hated' Ethereum due for a comeback says crypto icon Arthur Hayes

The BitMEX founder thinks a spending spree by the U.S. Treasury will help lift the price of Bitcoin.

Fortune

More people are trying medicinal cannabis for chronic pain. But does it work?

More Australians than ever are being prescribed medicinal cannabis.

The Conversation

Trump has Australia’s generic medicines in his sights. And no-one’s talking about it

While Australia was busy defending the Pharmaceutical Benefits Scheme against threats from the United States in recent weeks, another issue related to the supply and trade of medicines was flying under the radar.

The Conversation

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - AU

NAD boosters: Kendall Jenner and Hailey Bieber are into them, but do they actually stop ageing?

Despite social media hype, there is little evidence that the therapies, marketed as pills, shots and IV infusions, have any effects on ageing

Inverse

55 Years Ago, A Wildly Influential Disaster Thriller Invented A New Genre — And Changed Hollywood Forever

More than half a century after its release, Hollywood continues to pay its dues to 'Airport,' the grandaddy of the modern disaster movie.

The Guardian - AU

Botched Botox jabs can be dangerous. Some Australians don’t even realise what they’re receiving

The healthcare complaints watchdog says at least two unnamed Sydney practitioners, allegedly posing as accredited medical professionals, are under investigation

The Guardian - AU

Weight loss drug Wegovy approved to treat heart disease in overweight and obese Australian patients

TGA approved new indication for semaglutide drug in December 2024, but allocation to PBS still to be decided

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

Menopause hormone patches are in short supply. What are they? And how do they compare with other therapies?

The federal government yesterday released its response to the Senate inquiry into issues related to menopause. The inquiry recommended the government examine options to make menopause hormone therapy (MHT, or sometimes called hormone replacement therapy) more affordable and accessible, and address drug shortages.

The Conversation

Paracetamol pack sizes and availability are changing. Here’s what you need to know

Changes are coming into effect from February 1 about how paracetamol is sold in Australia.

Salon

Why Australia has embraced psychedelics

Australia recently became the first country to legalize both MDMA and psilocybin-assisted psychiatric therapy

The Conversation

Why a common asthma drug will now carry extra safety warnings about depression

Australia’s Therapeutic Goods Administration (TGA) recently issued a safety alert requiring extra warnings to be included with the asthma and hay fever drug montelukast.

The Conversation

No, you don’t need the ‘Barbie drug’ to tan, whatever TikTok says. Here’s why melanotan-II is so risky

TikTok and Instagram influencers have been peddling the “Barbie drug” to help you tan.

The Conversation

We looked at 54 medicinal cannabis websites to see if they followed the rules. Here’s what we found

A multi-million dollar business has developed in Australia to meet the demand for medicinal cannabis. Australians spent more than A$400 million on it in the first half of 2024 alone.

The Guardian - AU

Simon never linked the pain in his hands and feet to multivitamins – but a pathology test did

A growing number of consumers are presenting with symptoms linked to high levels of vitamin B6, pathologists say, while the supplement industry goes unpoliced

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the National Health and Medical Research Council

119 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.